A carregar...
An update on enzalutamide in the treatment of prostate cancer
Enzalutamide is an oral androgen receptor inhibitor that targets multiple steps in the androgen receptor signaling pathway. In the randomized phase III AFFIRM study, significant improvements in survival versus placebo were observed when enzalutamide was used as a treatment for patients with metastat...
Na minha lista:
| Publicado no: | Ther Adv Urol |
|---|---|
| Main Authors: | , , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
SAGE Publications
2015
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4294802/ https://ncbi.nlm.nih.gov/pubmed/25642291 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1177/1756287214555336 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|